SANFER
LIVE

Serial Number

88843993

Owner

Laboratorios Sanfer, S.A. de C.V.

Attorney

John M. Murphy

Filing Date

Mar 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SANFER Trademark

Serial Number: 88843993 • Registration: 6292319

SANFER is a trademark filed by Laboratorios Sanfer, S.A. de C.V. on March 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Laboratorios Sanfer, S.A. de C.V. (18 trademarks)

Col. Tlacopac
Ciudad de México 01049 , MX

Entity Type: 99

Trademark Details

Filing Date

March 23, 2020

Registration Date

March 16, 2021

Published for Opposition

December 29, 2020

Goods & Services

Medicines and pharmaceutical preparations, namely, pharmaceutical and medicinal products for ophthalmic use, antipyretics, analgesics, anesthetics, antiallergic medicines, antihistamines, antidotes, arsenic detoxification agents for medical purposes, benzol detoxification agents for medical purposes, chlorine detoxification agents for medical purposes, opium alkaloid preparations, smoking cessation preparations, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, anti-cancer preparations, anti-arthritic compositions and preparations, antiphlogistic analgesics, anti-rheumatic, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertensions, antitussives, expectorants, inhalant anesthetics, cardiovascular treatment preparations, analeptics, pharmaceutical preparations for treating hypertension, antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of heart rhythm disorders, antihypertensives, vasodilators, chemotherapeutics, antibiotic preparations, antifungal preparations, anti-tuberculous preparations, anti-leprotic agents, anti-protozoa preparations, medicinal preparations used in the treatment of malaria, antivirals, antiparasitic preparations, dermatological pharmaceutical products, antiparasitic preparations, dermatologics, radio-isotope markers for therapeutic or diagnostic use, dietary supplements, disinfectants, diuretics and anti-diuretics, antianemia drugs, anticoagulants, preparations for transfusions, enzymes for medical purposes, enzyme inhibitors, nutraceuticals for use as a dietary supplement for liver support, medicines for treatment of gastrointestinal diseases, antacids, diarrhea medication, anthelmintics, emetics, anti-emetic pharmaceutical preparations, medicated mouthwash for treating ulcers, antiflatulents, digestives for pharmaceutical purposes, medicines for use in indigestion, anti-inflammatories, laxatives, antiseptics, pharmaceutical preparations for the treatment and prevention of women's disorders and diseases, specifically, pharmaceutical preparations for assisted reproductive therapy, pharmaceutical preparations for the prevention and treatment of luteal phase defects and the prevention of miscarriages, immunosuppressants, dietary and nutritional supplements for anabolic use, antidiabetic preparations, dietary and nutritional supplements used for weight loss, pharmaceutical preparations for the treatment of anorexia; pharmaceutical agents affecting metabolism, pharmaceutical preparations for the treatment of Parkinson's disease, hypnotic sedatives, neuroleptics, tranquilizers, antidepressants, anti-psychotic pharmaceutical preparations, analeptics, neuropathical agents and other neurotropic agents, hormones for medical purposes, poly-opotherapeutic curative preparations for postponing manifestations of aging, estrogen preparations, progestogens, contraceptive preparations, androgen preparations, anti-hormone drugs, otorhinolaryngological preparations, otorhinolaryngological serums, vaccines, antispasmodics, vitamins, dietary and nutritional supplements containing coenzyme q10, multivitamin preparations, pharmaceutical preparations for sublingual use for treatment of heart problems; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 16, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 15, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 15, 2024 COAR
WITHDRAWAL OF ATTORNEY GRANTED
Jul 12, 2023 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jul 12, 2023 WOAR
REGISTERED-PRINCIPAL REGISTER
Mar 16, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 29, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 29, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2020 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 24, 2020 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Nov 10, 2020 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Oct 30, 2020 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 26, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 18, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2020 NWOS
NEW APPLICATION ENTERED
Mar 26, 2020 NWAP